By confirming that full-length VIRMA is enriched in the nucleus where m6A deposition occurs, while N-terminal VIRMA is generally cytoplasmic, our work explains why the previously reported role of N-terminal VIRMA in breast cancer is m6A-independent [17]. The gene discussed is VIRMA; the disease is breast cancer.